Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study (Q44300515)

1 December 2017

Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study (English)

1 reference

1 December 2017

1 reference

Kurugöl Z

1

1 reference

1 December 2017

Erensoy S

2

1 reference

1 December 2017

Akşit S

3

1 reference

1 December 2017

Egemen A

4

1 reference

1 December 2017

Bilgiç A

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 December 2017

1 reference

1 December 2017

19

1 reference

1 December 2017

28-29

1 reference

1 December 2017

3936-3939

1 reference

Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccine

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Vaccination against hepatitis B: comparison of intradermal and intramuscular administration of plasma derived and recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Suboptimal response following intradermal hepatitis B vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

An effective intradermal hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Immunogenicity of low-dose intramuscular and intradermal vaccination with recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Very-low-dose hepatitis B vaccine in newborn infants: an economic option for control in endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Twelve-year follow-up study of hepatitis B immunization of Senegalese infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900118-9

7 January 2021

10.1016/S0264-410X(01)00118-9

Identifiers

DOI

1 reference

1 December 2017

1 reference